tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market
TCRT
Alaunos Therapeutics
RESEARCH TOOLSreports

Alaunos Therapeutics (TCRT) Income Statement

693 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q4 2025), Alaunos Therapeutics's total revenue was $3.00K, a decrease of -25.00% from the same quarter last year. In Q4, Alaunos Therapeutics's net income was $-893.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.00K$ 10.00K$ 5.00K$ 2.92M$ 398.00K
Gross Profit
$ 5.00K$ 10.00K$ -4.80M$ 2.92M$ 398.00K
Operating Expenses
$ 4.23M$ 4.82M$ 29.47M$ 38.03M$ 77.95M
Depreciation and Amortization
$ 7.00K$ 2.00K$ 2.31M$ 2.76M$ 2.60M
EBITDA
$ -4.22M$ -4.68M$ -30.90M$ -31.82M$ -74.97M
Operating Income
$ -4.22M$ -4.81M$ -34.27M$ -35.10M$ -77.55M
Other Income/Expenses
$ 49.00K$ 133.00K$ -873.00K$ -2.63M$ -1.20M
Pretax Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Net Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Per Share Metrics
Basic EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Diluted EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Weighted Average Shares Outstanding
 1.95M 1.60M 1.60M 1.45M 1.43M
Weighted Average Shares Outstanding (Diluted)
 1.95M 1.60M 1.60M 1.45M 1.43M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History